Year |
Citation |
Score |
2015 |
Suffecool K, Rosenn B, Niederkofler EE, Kiernan UA, Foroutan J, Antwi K, Ribar A, Bapat P, Koren G. Insulin detemir does not cross the human placenta. Diabetes Care. 38: e20-1. PMID 25614695 DOI: 10.2337/Dc14-2090 |
0.684 |
|
2015 |
Suffecool K, Rosenn B, Niederkofler E, Kiernan U, Foroutan J, Koren G. 172: Insulin detemir in pregnancy: does it cross the placenta? American Journal of Obstetrics and Gynecology. 212: S100-S101. DOI: 10.1016/J.Ajog.2014.10.218 |
0.661 |
|
2014 |
Peterman S, Niederkofler EE, Phillips DA, Krastins B, Kiernan UA, Tubbs KA, Nedelkov D, Prakash A, Vogelsang MS, Schoeder T, Couchman L, Taylor DR, Moniz CF, Vadali G, Byram G, et al. An automated, high-throughput method for targeted quantification of intact insulin and its therapeutic analogs in human serum or plasma coupling mass spectrometric immunoassay with high resolution and accurate mass detection (MSIA-HR/AM). Proteomics. 14: 1445-56. PMID 24668948 DOI: 10.1002/Pmic.201300300 |
0.756 |
|
2013 |
Niederkofler EE, Phillips DA, Krastins B, Kulasingam V, Kiernan UA, Tubbs KA, Peterman SM, Prakash A, Diamandis EP, Lopez MF, Nedelkov D. Targeted selected reaction monitoring mass spectrometric immunoassay for insulin-like growth factor 1. Plos One. 8: e81125. PMID 24278387 DOI: 10.1371/Journal.Pone.0081125 |
0.763 |
|
2013 |
Sun Q, Kiernan UA, Shi L, Phillips DA, Kahn BB, Hu FB, Manson JE, Albert CM, Rexrode KM. Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation. 127: 1938-47. PMID 23584360 DOI: 10.1161/Circulationaha.113.002073 |
0.345 |
|
2013 |
Krastins B, Prakash A, Sarracino DA, Nedelkov D, Niederkofler EE, Kiernan UA, Nelson R, Vogelsang MS, Vadali G, Garces A, Sutton JN, Peterman S, Byram G, Darbouret B, Pérusse JR, et al. Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum. Clinical Biochemistry. 46: 399-410. PMID 23313081 DOI: 10.1016/J.Clinbiochem.2012.12.019 |
0.786 |
|
2013 |
Nedelkov D, Niederkofler E, Phillips D, Krastins B, Kiernan U, Tubbs K, Lopez M. Abstract 2508: Mass spectrometric immunoassay for insulin-like growth factor 1. Cancer Research. 73: 2508-2508. DOI: 10.1158/1538-7445.Am2013-2508 |
0.764 |
|
2013 |
Niederkofler E, Kiernan U. Measurement of IGF-1 by MSIA-SRM Genetic Engineering and Biotechnology News. 33: 38-39. DOI: 10.1089/Gen.33.3.20 |
0.66 |
|
2012 |
Norseen J, Hosooka T, Hammarstedt A, Yore MM, Kant S, Aryal P, Kiernan UA, Phillips DA, Maruyama H, Kraus BJ, Usheva A, Davis RJ, Smith U, Kahn BB. Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Molecular and Cellular Biology. 32: 2010-9. PMID 22431523 DOI: 10.1128/Mcb.06193-11 |
0.331 |
|
2012 |
Yang Q, Eskurza I, Kiernan UA, Phillips DA, Blüher M, Graham TE, Kahn BB. Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassay. Endocrinology. 153: 1519-27. PMID 22253430 DOI: 10.1210/En.2011-1750 |
0.341 |
|
2011 |
Kiernan UA, Phillips DA, Trenchevska O, Nedelkov D. Quantitative mass spectrometry evaluation of human retinol binding protein 4 and related variants. Plos One. 6: e17282. PMID 21479165 DOI: 10.1371/Journal.Pone.0017282 |
0.498 |
|
2011 |
Nedelkov D, Trenchevska O, Pupinoska A, Phillips D, Kamcheva E, Romevska S, Kiernan UA. Abstract 5114: Mass spectrometric immunoassays for quantitative determination of protein biomarker variants Cancer Research. 71: 5114-5114. DOI: 10.1158/1538-7445.Am2011-5114 |
0.579 |
|
2009 |
Kiernan UA, Tubbs KA, Niederkofler EE, Nedelkov D, Nelson RW. Mass Spectrometric Immunoassay in Urinary Proteomics Renal and Urinary Proteomics: Methods and Protocols. 333-347. DOI: 10.1002/9783527628612.ch25 |
0.731 |
|
2008 |
Kiernan UA. Biomarker rediscovery in diagnostics. Expert Opinion On Medical Diagnostics. 2: 1391-400. PMID 23496785 DOI: 10.1517/17530050802566488 |
0.302 |
|
2008 |
Kiernan UA, Hernandez L, Niederkofler EE, Tubbs KA, Nelson RW. MS-based phenotypic characterization of a human blood protein from urinary waste products. Proteomics. Clinical Applications. 2: 1019-24. PMID 21136902 DOI: 10.1002/Prca.200780118 |
0.793 |
|
2008 |
Niederkofler EE, Kiernan UA, O'Rear J, Menon S, Saghir S, Protter AA, Nelson RW, Schellenberger U. Detection of endogenous B-type natriuretic peptide at very low concentrations in patients with heart failure. Circulation. Heart Failure. 1: 258-64. PMID 19808300 DOI: 10.1161/Circheartfailure.108.790774 |
0.738 |
|
2008 |
Nelson RW, Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE. The Study of Microheterogeneity in Human Plasma Proteins: Application to Acute Myocardial Infarction Clinical Proteomics: From Diagnosis to Therapy. 217-229. DOI: 10.1002/9783527622153.ch15 |
0.703 |
|
2007 |
Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Volumetric mass spectrometry protein arrays. Methods in Molecular Biology (Clifton, N.J.). 382: 333-43. PMID 18220241 DOI: 10.1007/978-1-59745-304-2_21 |
0.788 |
|
2007 |
Kiernan UA. Quantitation of target proteins and post-translational modifications in affinity-based proteomics approaches. Expert Review of Proteomics. 4: 421-8. PMID 17552926 DOI: 10.1586/14789450.4.3.421 |
0.401 |
|
2006 |
Kiernan UA, Nedelkov D, Nelson RW. Multiplexed mass spectrometric immunoassay in biomarker research: a novel approach to the determination of a myocardial infarct. Journal of Proteome Research. 5: 2928-34. PMID 17081044 DOI: 10.1021/Pr060062+ |
0.41 |
|
2006 |
Kiernan UA, Addobbati R, Nedelkov D, Nelson RW. Quantitative multiplexed C-reactive protein mass spectrometric immunoassay. Journal of Proteome Research. 5: 1682-7. PMID 16823976 DOI: 10.1021/Pr0601133 |
0.561 |
|
2006 |
Kiernan UA, Nedelkov D, Niederkofler EE, Tubbs KA, Nelson RW. High-throughput affinity mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 328: 141-50. PMID 16785646 DOI: 10.1385/1-59745-026-X:141 |
0.795 |
|
2006 |
Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Population proteomics: the concept, attributes, and potential for cancer biomarker research. Molecular & Cellular Proteomics : McP. 5: 1811-8. PMID 16735302 DOI: 10.1074/Mcp.R600006-Mcp200 |
0.752 |
|
2006 |
Tubbs KA, Kiernan UA, Niederkofler EE, Nedelkov D, Bieber AL, Nelson RW. Development of recombinant-based mass spectrometric immunoassay with application to resistin expression profiling. Analytical Chemistry. 78: 3271-6. PMID 16689526 DOI: 10.1021/Ac060013G |
0.777 |
|
2006 |
Aksyonov SA, Bittner M, Bloom LB, Reha-Krantz LJ, Gould IR, Hayes MA, Kiernan UA, Niederkofler EE, Pizziconi V, Rivera RS, Williams DJ, Williams P. Multiplexed DNA sequencing-by-synthesis. Analytical Biochemistry. 348: 127-38. PMID 16289447 DOI: 10.1016/J.Ab.2005.10.001 |
0.689 |
|
2005 |
Tubbs KA, Kiernan UA, Niederkofler EE, Nedelkov D, Bieber AL, Nelson RW. High-throughput MS-based protein phenotyping: application to haptoglobin. Proteomics. 5: 5002-7. PMID 16281186 DOI: 10.1002/Pmic.200500176 |
0.766 |
|
2005 |
Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson RW. Investigating diversity in human plasma proteins. Proceedings of the National Academy of Sciences of the United States of America. 102: 10852-7. PMID 16043703 DOI: 10.1073/Pnas.0500426102 |
0.78 |
|
2004 |
Nelson RW, Nedelkov D, Tubbs KA, Kiernan UA. Quantitative mass spectrometric immunoassay of insulin like growth factor 1. Journal of Proteome Research. 3: 851-5. PMID 15359740 DOI: 10.1021/Pr0499388 |
0.483 |
|
2004 |
Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW. Proteomic characterization of novel serum amyloid P component variants from human plasma and urine. Proteomics. 4: 1825-9. PMID 15174148 DOI: 10.1002/Pmic.200300690 |
0.771 |
|
2004 |
Nedelkov D, Tubbs KA, Niederkofler EE, Kiernan UA, Nelson RW. High-throughput comprehensive analysis of human plasma proteins: a step toward population proteomics. Analytical Chemistry. 76: 1733-7. PMID 15018576 DOI: 10.1021/Ac035105+ |
0.792 |
|
2004 |
Medina ML, Kiernan UA, Francisco WA. Proteomic analysis of rutin-induced secreted proteins from Aspergillus flavus. Fungal Genetics and Biology : Fg & B. 41: 327-35. PMID 14761793 DOI: 10.1016/J.Fgb.2003.11.014 |
0.364 |
|
2004 |
Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW. Selected expression profiling of full-length proteins and their variants in human plasma Clinical Proteomics. 1: 7-16. DOI: 10.1385/Cp:1:1:007 |
0.791 |
|
2003 |
Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, McConnell E, Nelson RW. Comparative urine protein phenotyping using mass spectrometric immunoassay. Journal of Proteome Research. 2: 191-7. PMID 12716133 DOI: 10.1021/Pr025574C |
0.779 |
|
2003 |
Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Detection of novel truncated forms of human serum amyloid A protein in human plasma. Febs Letters. 537: 166-70. PMID 12606051 DOI: 10.1016/S0014-5793(03)00097-8 |
0.778 |
|
2003 |
Nedelkov D, Nelson RW, Kiernan UA, Niederkofler EE, Tubbs KA. Detection of bound and free IGF-1 and IGF-2 in human plasma via biomolecular interaction analysis mass spectrometry. Febs Letters. 536: 130-4. PMID 12586351 DOI: 10.1016/S0014-5793(03)00042-5 |
0.782 |
|
2003 |
Niederkofler EE, Tubbs KA, Kiernan UA, Nedelkov D, Nelson RW. Novel mass spectrometric immunoassays for the rapid structural characterization of plasma apolipoproteins. Journal of Lipid Research. 44: 630-9. PMID 12562854 DOI: 10.1194/Jlr.D200034-Jlr200 |
0.745 |
|
2002 |
Kiernan UA, Tubbs KA, Nedelkov D, Niederkofler EE, Nelson RW. Comparative phenotypic analyses of human plasma and urinary retinol binding protein using mass spectrometric immunoassay. Biochemical and Biophysical Research Communications. 297: 401-5. PMID 12237133 DOI: 10.1016/S0006-291X(02)02212-X |
0.801 |
|
2002 |
Kiernan UA, Black JA, Williams P, Nelson RW. High-throughput analysis of hemoglobin from neonates using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Clinical Chemistry. 48: 947-9. PMID 12029016 DOI: 10.1093/Clinchem/48.6.947 |
0.586 |
|
2002 |
Kiernan UA, Tubbs KA, Gruber K, Nedelkov D, Niederkofler EE, Williams P, Nelson RW. High-throughput protein characterization using mass spectrometric immunoassay. Analytical Biochemistry. 301: 49-56. PMID 11811966 DOI: 10.1006/Abio.2001.5478 |
0.812 |
|
2002 |
Kiernan UA, Williams P, Nelson RW. High throughput characterization of hemoglobin from neonates using MALDI-TOF MS Proceedings 50th Asms Conference On Mass Spectrometry and Allied Topics. 269-270. |
0.421 |
|
2002 |
Niederkofler EE, Nedelkov D, Tubbs KA, Kiernan UA, Williams P, Nelson RW. Rapid apolipoprotein phenotyping using mass spectrometric immunoassay approaches Proceedings 50th Asms Conference On Mass Spectrometry and Allied Topics. 253-254. |
0.742 |
|
2002 |
Kiernan UA, Nedelkov D, Tubbs KA, Niederkofler EE, Nelson RW. High-throughput analysis of human plasma proteins American Biotechnology Laboratory. 20: 26-28. |
0.754 |
|
2001 |
Niederkofler EE, Tubbs KA, Gruber K, Nedelkov D, Kiernan UA, Williams P, Nelson RW. Determination of beta-2 microglobulin levels in plasma using a high-throughput mass spectrometric immunoassay system. Analytical Chemistry. 73: 3294-9. PMID 11476228 DOI: 10.1021/Ac010143J |
0.799 |
|
Show low-probability matches. |